A 28-Year Study of the Course of Hepatitis Δ Infection: A Risk Factor for Cirrhosis and Hepatocellular Carcinoma
R. Romeo(Ospedale Maggiore), Massimo Colombo(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Roberto de Franchis(University of Milan), Angelo Sangiovanni(Ospedale Maggiore), E. Del Ninno(University of Milan), Guido Ronchi(University of Milan), Maria Grazia Rumi(University of Milan), Antonio Russo(Health Protection Agency)
Cited by 341
Related Papers
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
|Journal of Hepatology|2001|4.1k
Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline
|Endoscopy|2015|823
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
|Journal of Hepatology|2012|821
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
|Journal of Clinical Investigation|1996|661
The natural history of compensated cirrhosis due to hepatitis C virus
|Hepatology|2006|631